Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 472 out of 92,052 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 44,177 | 47,549 |
| Total Cites | 15,670 | 17,265 |
| H-index | 64 | 70 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 326 | 330 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 1,023 | 1,068 |
| Number of Single+First+Last Authored Papers | 95 | 95 |
| Total Cites to Single+First+Last Authored Papers | 3,391 | 3,572 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12,417 | 13,130 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.31 |
| Self-Citation Percentage |
9.24%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 437 out of 87,532 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40,965 | 44,255 |
| Total Cites | 15,352 | 16,910 |
| H-index | 63 | 69 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 319 | 323 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 1,010 | 1,055 |
| Number of Single+First+Last Authored Papers | 95 | 95 |
| Total Cites to Single+First+Last Authored Papers | 3,314 | 3,494 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12,125 | 12,823 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.32 |
| Self-Citation Percentage |
9.21%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 413 out of 82,885 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 38,089 | 42,155 |
| Total Cites | 14,955 | 16,485 |
| H-index | 63 | 66 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 314 | 318 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 996 | 1,041 |
| Number of Single+First+Last Authored Papers | 95 | 95 |
| Total Cites to Single+First+Last Authored Papers | 3,240 | 3,418 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11,770 | 12,455 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.32 |
| Self-Citation Percentage |
9.28%
|
|
McLeod, David G.
Uniformed Services University of the Health Sciences,
United States
2022 Rank: 35,736
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 393 out of 79,729 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35,736 | 39,539 |
| Total Cites | 14,371 | 15,866 |
| H-index | 62 | 65 |
| Hm-index | 21 | 22 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 306 | 310 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 961 | 1,006 |
| Number of Single+First+Last Authored Papers | 95 | 95 |
| Total Cites to Single+First+Last Authored Papers | 3,096 | 3,270 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11,272 | 11,935 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.33 |
| Self-Citation Percentage |
9.42%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.